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Abstract 
 Autism is a disorder that affects one in 59 children in the United States. The spectrum 
disorder affects individuals in early childhood and daily functioning. They may display limited 
spontaneous language and play and have difficulty in processing social messages. The literature 
review examines the benefits of non-pharmacological and pharmacological interventions in 
children with autism spectrum disorder (ASD). The proposed study will be guided by the 
phenomenology theory. Based on this theory, semi-structured interviews will focus on 
caregiver’s perceptions of their children’s reactions, needs, and care in healthcare settings. The 
literature review reveals how certain interventions and treatments have helped this population.  
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Introduction 
Autism, also known as autism spectrum disorder (ASD), is a developmental disorder 
characterized by repetitive and characteristic patterns of behavior and difficulties with social 
communication and interaction. “This may include limited spontaneous language and play, an 
inability to sustain conversations, and difficulty in processing social messages and cues that 
promote socially appropriate behaviors” (Pan, 2010). These limitations produce a challenge to 
children with the disability, parents, and school teachers. Horseback riding and swimming are 
beneficial in providing a multi-sensory environment that benefits the participant’s behaviors. 
Sensory integration interventions focus on understanding that “interferences in neurological 
processing and integration of sensory information disrupt the construction of purposeful 
behaviors” (Pfeiffer et al. 2011). In one study, data suggested that Ayres’s sensory integration 
had a positive effect on transitions, socialization, compliance, and general behavior regulation, 
evident during intervention session and in home environments (Watling et al. 2007). 
Psychotropic medications are apart of ASD treatment to address aggression, self-injurious 
behavior, hyperactivity, and other symptoms. However, there are increasing rates of 
polypharmacy of psychotropic medications with little to no evidence on the effect of these 
medications on the developing brain.  
  
BENEFITS OF NONPHARMACOLOGICAL AND PHARMACOLOGICAL TREATMENTS 
IN AUTISTIC CHILDREN 
 
5 
Problem Statement  
 Autism spectrum disorder (ASD), is a developmental disorder characterized by repetitive 
and characteristic patterns. The term “spectrum” refers to the wide range of symptoms, skills, 
and levels of disability in functioning that can occur in people with ASD. The symptoms are 
present from early childhood and affect daily functioning (NINDS, 2019). According to the 
Centers for Disease Control and Prevention (CDC) (2019), One in 59 children have been 
identified with ASD. Children diagnosed with ASD often show difficulties in performing their 
day-to-day performance in self-care, school and play skills. These deficits can lead to social 
isolation. Early behavioral interventions have been beneficial in helping children develop social 
and language skills such as physical therapy and art therapy. For example, horseback riding has 
been effective therapeutic option. Children with ASD improved significantly in areas such as 
sensory integration and directed attention as well as improved social motivation and sensory 
sensitivity. (Bass et al, 2009). Pharmacological treatment includes psychotropic medication like 
antidepressants, stimulants, or neuroleptics. However, the US Food and Drug Administration has 
indicated only one medication for use in ASD treatment as risperidone (Rosenberg et al, 2009).  
Purpose Statement  
The objective of the paper is to determine if there are benefits of nonpharmacological and 
pharmacological treatments provided together for autistic children, and if so, what are they. 
Literature Review 
The eight articles were found and selected with the keywords: autism, autism children, 
pharm, pharmacological, nonpharm, nonpharmacological, treatment, medication, therapy, 
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children, intervention, occupational therapy, and physical therapy. Articles were found in 
databases: Google Scholar, Elsevier, and Iceberg. The criteria for choosing the articles to review 
were: publishing year, treatment, non-treatment, interventions, children, adult, and autism. The 
research and findings were conducted and founded in between 1997-2016 with the primary 
diagnosis of the participants having Autism Spectrum Disorder. Refer to Appendix A for 
literature review table.  
The eight articles I have chosen have been categorized into physical activity, sensory 
integration, and pharmacology. Physical activity is an important part of a healthy lifestyle. 
Studies have reported positive physical and behavior effects for children with ASDs. Autism can 
present with symptoms that are categorized into somatosensory disturbance, atypical 
developmental patterns, mood disturbances, and problems with attention and safety. Another 
common ASD treatment regimen incorporates pharmacological interventions. 
Physical Activity 
The article, Effects of water exercise swimming program on aquatic skills and social 
behaviors in children with autism spectrum disorders by Pan (2010) explores the benefits of a 10 
week water exercise swimming program (WESP) on aquatic skills and social behaviors of 
participants with ASD. Physical activity in the aquatic environment enables initiation of 
independent movements that are hard to accomplish on land due to gravity. The remedial 
utilization of water exercises or swimming in children with ASDs is believed to foster language 
development and self-concept. 
The individual’s aquatic skills and social behavior data were collected three times, the 
first time at entry to create a baseline, a second time after ten weeks of WESP or regular activity, 
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and a third time after another ten weeks (Pan, 2010). With regards to swimming experience, few 
of the subjects have gone to swimming lessons prior to the study however, all participants had 
restricted breathing, floating, and stroke abilities dependent on parent reports and first evaluation 
at study entry. Participants were split into two groups, A and B. Group A received WESP for the 
first ten weeks, second assessment after the WESP, then regular treatment or activity and third 
assessment. The arrangement was reversed for subjects in group B. The study lasted 21 weeks, 
ten weeks WESP, ten weeks control, and one week transition.  
“During each WESP session, two children with ASDs were paired with the same 
instructor each session. Each session was divided into four categories: (A) social and floor 
warm-up activities, (B) one-to-two small group instruction, (C) whole group games/activities, 
and (D) cool-down activities” (Pan, 2010). The student to instructor ratio allows for individual 
instruction, allowing the swim instructor to follow the student’s progression and to adapt to other 
factors and challenges. WESP also provides games and group activities, allowing the student to 
become apart of the class while gaining independence.  
“Results indicate that WESP improved the aquatic skills in four out of five stages as 
measured with percentage scores, and decreased the total antisocial behavior problems in 
children with ASDs” (Pan, 2010). The results yielded from the study were similar to other 
studies conducted on physical activity -- “children with ASDs showed improvement in scores on 
water orientation skills, breathing skills, floating skills, stroke skills, and entry and exit skills 
over an extended period of program” (Pan, 2010). The participants were assessed in balance, 
speed, agility, power, upper and lower extremity muscle strength, flexibility, and cardio-
respiratory endurance, showing an increase in the said increments.  
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To maximize potential positive impacts, WESP was carefully designed according to 
variables such as: child’s age, disability, experiences on the water, play skills, and interests and 
needs of the family (Pan, 2010). WESP resulted in decreased antisocial behavior problems but 
not increase social competence behaviors. However, many children with autism benefit from 
watching the positive social interactions of others.  
Similarly, another article The Effect of Therapeutic Horseback Riding on Social 
Functioning in Children with Autism Bass et al., (2009) considers the effects of a 12 week 
therapeutic horseback riding intervention on social functioning in children with autism. Research 
has suggested animal assisted therapy can influence physiological factors. “Therapeutic 
horseback riding, a subtype of animal assisted activities, has also been [utilized] to treat 
populations with both physical and mental disabilities” (Bass et al., 2009). Therapeutic 
horseback riding is defined as “using horseback riding treatment to improve posture, balance, 
and mobility while developing a therapeutic bond between the patient and the horse” (Bass et al., 
2009). Therapeutic horseback riding stimulates multiple disciplines of functioning and may be 
appropriate for children with neurological disorder who often present a blend of motor, 
psychological, and social incapacities.  
 Bass et al. (2009) used Social Responsiveness Scale (SRS) and Sensory Profile (SP) to 
assess social functioning pre- and post-intervention. The Social Responsiveness Scale is a 65-
item questionnaire that measures the severity of ASD in natural social settings. The five 
treatment subscales are: social awareness, social cognition, social communication, social 
motivation, and autistic mannerisms. The Sensory Profile is a 125-item questionnaire that 
addresses the overall social function and the degree to which children exhibit problems in 
sensory processing, modulation, and behavioral and emotional responses (Bass et al., 2009).  
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 Each child in the treatment group received a therapeutic riding session for an hour a 
week, over the span of 12 weeks. The mounting and dismounting of the horse was aimed at 
stimulating verbal communication, proprioception, and vestibular processing. Arm circles, trunk 
twists, and toe touches were designed to condition the individual for the physical demands of 
horseback riding.  
Riding the horse was “designed to stimulate sensory seeking, as well as gross and fine 
motor domains” (Bass et al., 2009). Instructors led the games that focused on social and 
communication skills. Examples of the games included “Simon says,” red light/green light, catch 
and throw, and letter games. The horsemanship segment allowed children to learn to properly 
groom and care for their horse by learning to identify grooming tools and bathing tools.  
Bass et al (2009) verbally and physically reinforced participants with high-fives and hugs 
upon completion of each exercise. Instructors and volunteers made efforts to maintain eye 
contact with all participants through the therapy session. “Results revealed that the experimental 
group significantly increased between pre- and post-testing, [whereas] the control group only 
marginally increased” (Bass et al., 2009). The study suggest that therapeutic horseback riding  
may be an efficacious remedial choice for children with autism spectrum disorders. Children in 
the experimental group improved in critical areas such as sensory integration and directed 
attention. They also demonstrated improved social motivation, sensory sensitivity, and a 
decrease in inattention and distractibility (Bass et al., 2009). 
Individuals diagnosed with ASDs is widely increasing, therefore it is important to 
identify recreational activity that may benefit this population. Swimming can enhance a child’s 
competence and foster an appreciation of proficient movement. “The kinesthetic stimulation 
provided by horseback riding is unique compared to generic forms of physical therapy” (Bass et 
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al., 2009). Overall, both swimming and horseback riding yielded results in improved and desired 
behavior in independence and directed attention. These studies are the first of its kind and future 
studies should increase the length and number of sessions to test and further develop more 
intense forms of physical activity interventions.  
Sensory Integration 
Pfeiffer et al. (2011) conducted a study called Effectiveness of Sensory Integration 
Interventions in Children with Autism Spectrum Disorders: A Pilot Study. The purpose of this 
study was to establish a randomized control trial research, identify appropriate outcome 
measures, and address the effectiveness of sensory integration (SI) intervention in children with 
ASD (Pfeiffer et al., 2011). Sensory processing disorder (SPD) is quite common among children 
with ASD; reports in the literature range from 42%-88% (Pfeiffer et al., 2011). Sensory 
integration disorders often lead people to have extreme responses to what others consider mild 
stimuli, or to completely shut down and withdraw from society. With sensory processing 
abnormalities, typical behavior displayed includes stereotypic motor movements, aimless 
running, aggression, and self-injurious behaviors. These behaviors can interfere with a child’s 
ability to engage or learn in therapeutic activities.  
 Sensory integration (SI) theory concentrate on the neurological processing of sensory 
data. SI theory is based on the comprehension that impedances in neurological processing and 
integration of tactile data disrupts the development of purposeful behaviors. The goals of 
treatment were to improve attention and cognitive function while decreasing disruptive and 
repetitive behaviors. Participants were split into two, one group received SI interventions and the 
other group received fine motor (FM) interventions. “Interventions were provided in the context 
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of the summer therapeutics activities program. Activities are to help the nervous system 
modulate, organize, and integrate information from the environment, resulting in future adaptive 
responses” (Pfeiffer et al., 2011).  
 SI-based treatment involves meaningful therapeutic activities distinguished by 
enhancement of sensation, touch, hearing, proprioceptive, active participation, and adaptive 
interaction. The interventions are individualized to the needs of each child but include the 10 key 
therapeutic strategies: arranging the room to entice engagement, ensuring physical safety, 
presenting sensory opportunities, attaining and maintaining optimal arousal levels, tailoring 
activities to present the just-right challenge, ensuring that activities are successful, guiding the 
self-regulation of behavior, creating a playful context, collaborating in activity, and fostering 
therapeutic alliances (Pfeiffer et al., 2011).  
 The fine motor treatment group participated in individual sessions with an occupational 
therapy graduate student. The FM interventions focused three activity areas of constructional, 
drawing and writing, and FM crafts. According to Pfeiffer et al, (2011) studies, FM interventions 
were to meet the fidelity criteria of: appropriate supports provided for the child to successfully 
accomplish the tasks while challenging their fine motor and visual-motor skills, interventions 
based on therapeutic needs of the child in areas of visual and FM skills, interventions based on 
the child’s interests to maintain attention and focus on the task, seating and positioning of the 
child adapted to address their specific size and motor support needs, as well as activities that do 
not provide full-body proprioceptive, vestibular, or tactile sensory input. During the pretest phase 
of the study, it was discovered that the participants lacked occupational therapy services within 
the program due to limited funding.  
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Measurement tools were used to further assess in-depth criteria. Sensory processing 
measure (SPM) is a 4-point Likert-type scale that surveys processing issues, praxis, and social 
participation, providing a complete picture of the child’s sensory processing difficulties at 
school, home, and in the community. The SPM was used to distinguish the two groups. Social 
responsiveness scale (SRS) is a 65-item rating scale that measures a child’s social impairments 
such as social awareness, social information processing, capacity for social communication, 
social anxiety and avoidance, and autistic preoccupations and traits. Results were used to 
differentiate children with PPD and other diagnostic conditions, showcasing strong discriminant 
variability (Pfeiffer et al., 2011).  
The Quick neurological screening test, 2nd edition (QNST-II), assesses 15 areas of 
neurological integration that was used to predict scores and results in areas including praxis, 
hand agility, visual tracking, and motor skills. The goal attainment scaling (GAS) is an objective 
setting procedure used to determine intervention outcomes explicitly relevant to individuals and 
their families. The purpose of the tool was to develop goals with the parents to ensure the goals 
were relevant and appropriate for the child. Vineland adaptive behavior scales, 2nd edition 
(VABS-2) is “an individually administered measure of adaptive behaviors that assesses the 
domains of communication, daily living skills, socialization, and motor skills” (Pfeiffer et al., 
2011). This measurement tool was used to control validity.  
In the study, results demonstrated significant changes in the autistic mannerisms. “Post 
Intervention differences in social responsiveness between the SI and FM groups [showed that] 
children in the SI group had significantly fewer autistic mannerisms after interventions” (Pfeiffer 
et al., 2011). Pfeiffer mentions a study where autitic people who use self-stimulatory behaviors 
allowed them to process sensory information without sensory overload. But, the evident 
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reduction of autistic mannerisms and self-regulatory behaviors may indicate a better ability to 
process sensory stimuli without the need for regulatory strategies (Pfeiffer et al., 2011). A 
significant difference was noted in the QNST-2 testing. Participants who received the SI 
interventions were more competent in completing the standardized test post-test as opposed to 
their counterpart.  
In a study analyzed in 2007, a group of researchers examined the effects of Ayres’s 
sensory integration intervention on the behavior and task engagement of young children with 
ASD in the research article Immediate Effect of Ayres’s Sensory Integration-Based Occupational 
Therapy Intervention on Children with Autism Spectrum Disorders. Watling and Dietz created 
individualized material for each child’s baseline. Some materials used in the treatment phases 
were swings, rope ladder, small trampoline, scooter board and ramp, balance beams, and toys 
that challenge bilateral coordination and manipulation (Watling, 2007). Ten activities met the 
criteria of activity demands matching the cognitive and fine motor skills of the child and the 
activity having the tendency to evoke  attention and engagement. Examples of the activities were 
puzzles, stickers, beads and strings, and blocks.  
The study sessions had three phases, familiarization, baseline, and treatment. The 
familiarization phase consisted of the child and occupational therapist freely playing with the 
specified toys. Baseline sessions were like free-play scenarios, similar to a preschool 
environment. “The therapist continually observed the child’s responses to activities and made 
modifications as needed to offer an appropriate level of challenge that encouraged the 
development of new skills” (Watling, 2007). All study sessions were videotaped because review 
footage is the most common method of data analysis for single-subject research. According to 
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Watling (2007), an additional benefit to visual inspection is that it increases confidence that 
observed performance changes are due to intervention.  
According to Watling’s data, it can be presumed that Ayres’s sensory integration had a 
positive effect on transitions, socialization, compliance, and general behavior regulation; evident 
during intervention session and in home environments. “The present study found that the rates of 
undesired behavior immediately after Ayres’s sensory integration were similar to those after 
playing conditions” (Watling, 2007). The children showed improvements in transitions between 
activities. Findings for engagement were not supportive of Ayres’s sensory integration but one 
participant demonstrated “his highest rates of engagements on the 4 of the last 5 days of study, 
suggesting that his task engagement improved over time” (Watling, 2007). Studies on Ayres’s 
sensory integration for children with ASD is limited, therefore it is ideal to have well-controlled 
studies and reliable outcome measures to understand the effectiveness of SI. The study was to 
record subjective data that may guide future research in the area. The low population sample, 
short trials, and potential for bias are limitations in both research articles.  
Pharmacology   
Psychotropic Medication Use Among Children With Autism Spectrum Disorders Enrolled 
in a National Registry, 2007-2008 by Rosenberg et al. (2009), investigates the trends of 
prescription medication for children with autism. The US Food and Drug Administration only 
indicated Risperidone for treatment of autism but many other medications are also prescribed. 
“Treatment of ASD often includes psychotropic medications to address aggression, self-injurious 
behavior, hyperactivity, anxiety, sleep problems, and other symptoms common in children with 
these disorders” (Rosenberg et al., 2009). As stated in previous studies, it is estimated that 30-
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60% of children with ASD use at least one psychotropic medication, predominantly 
antidepressants, stimulants, or neuroleptics (Rosenberg et al., 2009).  
Between April 2007 to October 2018, a total of 5,181 children were sampled and findings 
concluded that the sample was predominantly male (83%), age 6-11 years old (49%), and often 
reported psychiatric comorbidities (39% with ≥ 1 comorbidity) (Rosenberg et al., 2009). 
Older children were more likely to be prescribed medication than younger children. Those who 
reported no insurance coverage were less likely to be on more than two medications compared to 
individuals who had private insurance, Medicaid, or a combination of both. According to the 
results, psychotropic medication use is associated with geographic characteristics. “Increased 
medication use in poorer areas may reflect that these children have less access to behavioral and 
education supports and thus use more pharmaceutical interventions” (Rosenberg et al., 2009). 
This greatly reflects the access to specialty health care and inconsistent guidelines for 
pharmaceutical management of ASD.  
Similarly, Psychotropic Medication Use and Polypharmacy in Children With Autism 
Spectrum Disorders by Spencer et al., (2013) examines the rates and predictors of psychotropic 
use and multiclass polypharmacy among commercially insured children with ASD. Research 
shows increasing rates of psychotropic uses and polypharmacy in children overall and in children 
with ASD. General apprehension about such medications are the absence of proof reporting the 
safe or adequacy of psychotropic treatment during adolescence. Developing brains and bodies 
may be vulnerable to organic impacts.  
 Data was gathered through a large database associated with a large US commercial health 
plan that discovered “a total of 33, 565 children with ASD who had at least 6 months of months 
of continuous medical, pharmacy, and behavioral health care coverage between January 2001 
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and December 2009 were identified” (Spencer et al., 2013). Household income, ethnicity, age, 
geographic location, co-occuring conditions, and having had a specialist visit were seen as 
altogether significantly related to psychotropic use and polypharmacy. Spencer et al. (2013) 
identified that common class combinations were antidepressants and ADD medications (38% of 
subjects), antipsychotic and ADD medications (28%), antipsychotics and antidepressants (20%), 
and antipsychotic, antidepressant, and ADD medications (18%). A large proportion of children 
who have autism have comorbidities like epilepsy and seizures, ADD, anxiety, depression, and 
bipolar disorder. This population are psychotropic users and more than half are users of 
polypharmacy. Results showed that common combinations of classes were antidepressants and 
ADD medications, antipsychotics and ADD medications, antipsychotics and antidepressants, and 
all 3-- antipsychotics, antidepressants, and ADD medications (Spencer et al., 2013). Such 
statistics are beneficial in understanding treatments for children and potentially older children 
with ASD.  
 In Risperidone and Explosive Aggressive Autism by Horrigan and Barnhill (1997) the 
objective was to further understand Risperidone and its effect in a broader age range of severe 
explosive autistic individuals. “Risperidone is a benzisoxazole with potent antipsychotic 
properties” (Horrigan, 1997). The drug reduced extrapyramidal side effects with a quick onset of 
action. 11 male patients age 6 to 34 years old participating in the study. Initial evaluation 
concluded of a physical examination, neurological examination, and blood work as needed. 
Ripseridone was started at 0.5 mg orally, once daily at bedtime as disturned sleep hygiene was 
exacerbating, and aggravating factor found in eight of the patients (Horrigan, 1997). Doses were 
titrated higher, gauged by adult caretaker reports in increments of 0.25-0.5 mg every 5 to 7 days.  
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 Subjects had follow-up visits to further monitor side effects such as changes in appetite, 
somatic complaints, mood changes, quality of social interactions, compulsive or stereotypical 
behaviors, and changes in the pattern of self-directed and externally directed aggression. Results 
showed major clinical improvement in each patient as early as the first 24 hours after risperidone 
was administered. “Aggression (hitting, kicking, biting), self-injury (head banging, self-biting), 
explosivity (sudden, intense tantrums occurring with little or no provocation), overactivity 
(persistently elevated levels of motor activity), and poor sleep hygiene (difficulty falling asleep, 
difficulty staying asleep) diminished most significantly” (Horrigan, 1997). None of the patients 
reported dizziness or other side effect that may propose orthostatic hypotension, changes in pulse 
or blood pressure. The precise dose of risperidone was achieved for each subject after a 4 week 
period. It was noted that temper outbursts were the strongest and most consistent drop in all 
participants. Overall, the study was indicative that risperidone therapy was most effective in the 
subjects of explosive, autistic males. However, more studies are to be done to study more serious 
side effects such as neuroleptic malignant syndrome and tardive dyskinesia.  
 Intranasal oxytocin versus placebo in the treatment of adults with autism spectrum 
disorders: a randomized controlled trial by Anagostou, Soorya, Chaplin, Bartz, Halpern, 
Wassermanm, Wang, Pepa, Tanel, Kushki, Hollander (2016), the objective is to study the safety 
and therapeutic effects of intranasal oxytocin versus placebo in adults with ASD. Oxytocin has a 
unique role in influence social behaviors and has potential for generating animal models with 
behavior deficits relevant to ASD (Anagostou, 2016). Evidence has shown that individuals with 
ASD have a reduction of oxytocin mRNA in the temporal cortex which is associated with 
hypermethylation. “Oxytocin has been shown to play a role in social recognition, memory, and 
attachment, as well as in stereotyped behaviors [like] exaggerated grooming” (Anagostou, 2016). 
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The current study is following another study where intranasal oxytocin (IN-ONT) promoted trust 
and prosocial behavior in humans. “Participants receiving oxytocin showed reduced amygdala 
activation to social stimuli more than nonsocial kinds of stimuli, further suggesting that oxytocin 
is mediating human social behavior” (Anagostou, 2016).  
 The randomized, double-blind, placebo-controlled, parallel design trial study was quite 
selective wherein participants were to be 18 to 60 years old and on stable pharmacological or non 
pharmacological treatments for at least 3 months. Exclusion criteria included bipolar disorder, 
psychosis, post-traumatic stress disorder, schizophrenia, respirtal, renal, hepatic or 
gastrointestinal disease. Sexually active women were to be on two barriers of contraceptives and 
no hormonal birth control. Oxytocin and placebo were administered via nasal spray twice-daily 
for six weeks. Anagostou et al., assessed the participants every two weeks for improvement 
ratings, vital signs, and measures of repetitive behaviors. Subjects kept a medication diary to 
document when they took the medication. “The diary was reviewed at every visit and the study 
clinician and participant problem-solved together in the case of missed doses to improve 
compliance” (Anagostou, 2016).  
 In conclusion to the study, oxytocin was well tolerated with no serious side effects 
reported. In the oxytocin group, two have reported increased irritability of mild to moderate 
severity and two others have reported allergy symptoms. In the placebo group, there were reports 
of mild cough, depressed mood, and fatigue (Anagostou, 2016). Although there were no 
significant differences found between blood work in oxytocin and placebo, it is the first study to 
trial daily administration of IN-OXT in autistic individuals. Risperidone is a common 
pharmacological intervention yet side effects may be severe. Other treatments such as oxytocin is 
a newer study that may employ as an alternative.  
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Physical activity is beneficial to everyone. Swimming exercises the whole body without 
putting excessive stress or tension on specific body parts. Participants responded well to the 
intervention and demonstrated independence and skills. Therapeutic horseback riding allowed 
the subjects to better enhance their sensory integration and directed attention. Sensory processing 
disorder is a common symptoms of autism where individuals may display extreme responses and 
behaviors. Ayres’s sensory integration interventions aims were to improve attention and 
cognitive function. Data has shown a positive effect on socialization, compliance and regulation 
of general behavior. Pharmacological treatment is common in many children and often treats 
symptoms non pharmacological therapy cannot help. Risperidone is a commonly prescribed 
medication that has benefited those with explosive autism and other unwanted symptoms. Trial 
run of oxytocin has benefitted some individuals as well.  
Autism is a disease that has affected many. The wide broad spectrum of symptoms 
arrayment makes treatment difficult and highly individualized in both pharmacologic and 
nonpharmacologic interventions. Some gaps identified in the current research are population 
sizes, short duration of testing, and limited research on pharmacological trends. Population sizes 
ranged from 12 to 34 participants lasting for a few months. More research is to be done on a 
grand scale. Another unexplored topic is the adaptability to hospitals. Hospitals provide an 
unpredictable timeline which may create frustration among people with ASD. There are often 
symptoms that non-pharmacological interventions cannot prevent or fix. Pharmacological 
interventions and medication are a necessary aid in other symptomatic management.  
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Research Proposal  
What are the caregiver’s perceptions of their children’s reactions, needs, and care in 
healthcare settings? Studies have shown the benefits of physical activity, sensory integration, and 
pharmacology in the treatment of children with ASD. Physical activity yielded positive attitude 
changes as well as learned skills in swimming and horseback riding. Sensory integration 
interventions demonstrated fewer autistic mannerisms as well as decreased undesired behaviors 
such as: stereotypical motor movements, aimless running, aggression, and self-injurious 
behaviors. Due to the wide array of symptoms, each child has an individualized care and set of 
interventions. It has been noted that medication is given to treat symptoms that are 
unmanageable by non-pharmaceutical interventions. “Treatment of ASD often includes 
psychotropic medications to address aggression, self-injurious behavior, hyperactivity, anxiety, 
sleep problems, and other symptoms common in children with these disorders” (Rosenberg et al., 
2009). These interventions benefit children in the outside world. However, there is limited 
research in understanding children with ASD in the healthcare setting.  
Theoretical Framework  
 The theoretical framework used to guide this research was phenomenology. This theory 
describes the lived experience with the aim of finding the meaning in experiences and making 
sense of it (Schmidt & Brown, 2012). This study will provide insight from caregivers and 
children with ASD of their lived experiences in hospitals and healthcare settings. Caregivers’ 
perceptions were studied to distinguish and depict themes and trends and to discover approaches 
to help children have an easy transition in such experiences. The phenomenology theory design 
will obtain data through semi-structured interviews with caregivers. Through the interviews, data 
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will be collected and analyzed, resulting in theme descriptions. The primary research aim is to 
further understand caregiver perceptions of their children with ASD and their visits with 
healthcare providers.  
Ethical Considerations 
 The five ethical principles I will abide to are: minimizing risk of harm, obtaining 
informed consent, protecting anonymity and confidentiality, avoiding deceptive practices, and 
providing the right to withdraw (Laerd Dissertation, 2012). I will obtain consent for the audio 
recording of the interviews. I will assign a study ID to each participant and no private 
information will be revealed. Participants confidentiality will be maintained. Recruitment, data 
collection, and ethical considerations will begin after the study was approved by the Internal 
Review Board of the Dominican University of California.  
Potential ethical issues include: informed consent, beneficence, respect for anonymity 
and confidentiality. Informed consent is to ensure the patient’s right to autonomy is protected. “It 
is essential to describe any physical harm or discomfort, any invasion of privacy and any threat 
to dignity as well as how the subjects will be compensated in that case” (Burns, 2015). In 
interviews, participants share intimate details that may open old wounds. If risks outweigh the 
benefits, the study will be revised (Burns, 2015). Anonymity protects the subject’s identity and 
cannot be linked with the personal responses given while confidentiality allows individuals to 
give and withhold information as they choose.  
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Research Method  
The qualitative study will use a design based in phenomenology to describe the lived 
experiences of caregivers of children with ASD. The standardized open-ended interview is a 
structured study design where participants are asked identical questions with open-ended 
responses. The open-ended questions allow participants to contribute detailed information. The 
sample population will represent caregivers of children with autism spectrum disorder.  
The projected sample size of this study will include six participants, including family 
members and caregivers. Participants will be recruited through social media, schools, or pediatric 
hospitals, and autism associated organizations where participants are eligible to request for more 
information. Once informed consent is obtained, demographic information will be collected. The 
semi-structured interviews will be voice recorded.  
Research focusing on the experiences of individuals with autism and their families is on 
the rise. This is due to the growing attention on individuals with ASD and recognizing the impact 
of ASD on families. In Qualitative research with families living with autism spectrum disorder: 
Recommendations for conducting semistructured interviews by Cridland et al. (2015), provides 
insight and experiences of a research team conducting a range of qualitative methods, 
particularly semi structured interviews. “Semi-structured interviews involve in-depth 
conversations between the researcher and interviewee, which have an overall purpose prompted 
by the research aims, but are strongly guided by the interviewee’s perceptions, opinions, and 
experiences” (Cridland et al., 2015). Analysis and interpretation of qualitative research can be 
influenced by other variables such as preparation, data collection, transcribing, and reading of 
transcripts. I will use content analysis to search for repeated phrases or words and from the 
words, themes will be developed.  
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Conclusion  
Autism is a disorder that affects individuals differently. The spectrum of symptoms vary 
with very individualized care and treatment. The literature review suggests that there are many 
interventions involved in treating ASD. Non-pharmacological and pharmacological interventions 
intermingle and treat other symptoms that other interventions cannot. A common and successful 
intercession was physical activity. Although exercises varied, sensory integration and directed 
attention improved. To combat those with sensory processing disorders, sensory integration 
interventions were implemented and displayed enhancement in attention and cognitive function. 
Pharmacological studies identified that a majority of children with ASD use at least one 
psychotropic medication to combat symptoms of aggression, self-injury, explosivity, 
overactivity, and poor sleep hygiene. However,  
Implications for Nursing Practice  
 In order to properly care for children with ASD, the nurse and health care team must 
understand non-pharmaceutical and pharmaceutical interventions that have been implemented 
into care. This literature review suggests that there are many ways to treat temperaments. As 
nurses, the people they encounter at the hospital may range from individuals with disabilities to 
disorders and diseases. Children and adults alike have social and communication difficulties that 
may make it more difficult to communicate and have their healthcare needs met.  
 The focus is to help children in the acute setting. Caring for individuals with ASD has 
come a long way. Identifying people with ASD has played a role in improving their overall 
quality of life. Staff who conduct clinical assessment should look for indicators of ASD through 
the patient’s social interactions, communication, and behaviors as well as responding to the 
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concerns raised by parents. Nurses can play a role in reducing exacerbations of unwanted 
behaviors, education to family members, caregivers, and peers. This can be especially important 
for children with autism who are admitted to the hospital for acute exacerbations. 
 The literature review displayed non-pharmacological and pharmacological interventions 
currently available for children with ASD. The literature suggests that each intervention is 
effective but durations of the study can be elongated as well as an increase in sample size and 
follow-ups. It is still unknown as to what long-term effects these interventions, both non-
pharmacological and pharmacological may have on the children and their growing brain. ASD 
continues to present obstacles in the daily lives of children and their families. Research is needed 
to further understand better coping mechanisms and styles that may be implemented on a global 
scale. 
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Author (Year) 
Title 
Citation 
Purpose Design and Sample Methods Limitations and 
Strengths 
Findings 
Intranasal 
oxytocin versus 
placebo in the 
treatment of 
adults with autism 
spectrum 
disorders: a 
randomized 
controlled trial 
 
 
Anagnostou, E., 
Soorya, L., 
Chaplin, W., 
Bartz, J., Halpern, 
D., Wasserman, 
S., … Hollander, 
E. (2012). 
Intranasal 
oxytocin versus 
placebo in the 
treatment of 
adults with autism 
spectrum 
disorders: a 
randomized 
controlled trial. 
Molecular 
To study the 
supports the 
therapeutic 
potential and safety 
of daily 
administration of 
IN-OXT for social 
cognition/function 
deficits and 
possibly repetitive 
behaviors in adults 
with ASD 
- Pilot, randomized, 
double-blind, 
placebo-controlled, 
parallel design trial 
- 19 adults with 
ASD, 16 males  
 
- Recruited through 
advertisements in 
local media 
 
- Subjects were 
randomized to 24 
IU intranasal 
oxytocin or placebo 
in the morning and 
afternoon for 6 
weeks 
 
 
Limitations  
- Duration of the 
study was only 6 
weeks and as such 
we may have 
underestimated the 
potential impact of 
oxytocin on core 
symptom domains 
 
- The three female 
participants were all 
premenopausal and 
on no hormonal 
contraception, but we 
did not collect data 
on the time of 
menstrual cycle that 
may potentially 
interact with 
oxytocin 
 
- Study did not 
follow-up the 
participants once the 
medication had been 
stopped 
 
- 6-week use of IN-
OXT versus placebo 
resulted in 
improvements in 
aspects of social 
cognition, repetitive 
behaviors and 
emotional wellbeing 
in some, although not 
all 
 
- Study did not report 
any serious adverse 
effects and IN-OXT 
was well tolerated 
 
- Participants 
administered with 
oxytocin showed 
improved positive 
evaluations of 
appearance and 
speech performance, 
suggesting that 
following exposure 
therapy the 
administration of 
oxytocin improved 
BENEFITS OF NONPHARMACOLOGICAL AND PHARMACOLOGICAL TREATMENTS IN AUTISTIC CHILDREN 
 
30 
Author (Year) 
Title 
Citation 
Purpose Design and Sample Methods Limitations and 
Strengths 
Findings 
Autism, 3(1), 16–
24. 
https://doi.org/10.
1186/2040-2392-
3-16 
 
Strengths  
- Pilot study suggests 
that there is 
therapeutic potential 
to daily 
administration of 
intranasal oxytocin in 
adults with ASD and 
that larger and longer 
studies are warranted 
 
- First study to 
employ an acute 
treatment trial of 
daily administration 
of IN-OXT in ASD 
the mental 
representations of 
self 
The Effects of 
Therapeutic 
Horseback Riding 
on Social 
Functioning in 
Children with 
Autism 
 
 
Bass MM, 
Duchowny CA, & 
Llabre MM. 
To study the 
effects of 
therapeutic 
horseback riding 
on social 
functioning in 
children with 
autism 
 
 
 
- Quasi-
experimental  
- Hypothesis testing  
 
- Participants 
randomly assigned 
to experimental or 
control group  
 
- 34 children with 
ASD had 12 weeks 
of therapeutic 
- Social Responsive 
Scale (SRS) and 
Sensory Profile 
(SP) were used to 
assess social 
functioning at pre 
and post 
intervention 
 
- Received a 
therapeutic riding 
session 1 hr/week 
Limitations 
- No information 
about medication 
regimens  
 
- Limited to case 
reports and 
descriptive studies  
 
- Unknown if parents 
of participants in 
either 
- Results suggest that 
therapeutic 
horseback riding may 
be an efficacious 
therapeutic option for 
children with ASD 
 
- Compared to 
control group, ASD 
children in the 
experimental group 
improved in critical 
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Author (Year) 
Title 
Citation 
Purpose Design and Sample Methods Limitations and 
Strengths 
Findings 
(2009). The effect 
of therapeutic 
horseback riding 
on social 
functioning in 
children with 
autism. Journal of 
Autism & 
Developmental 
Disorders, 39(9), 
1261–1267. 
https://doi.org/10.
1007/s10803-009-
0734-3 
 
 
horseback riding 
and one post testing 
session  
over span of 12 
weeks 
  
- 2 x 2 mixed design 
repeated measure 
analysis of variance 
(ANOVA) 
examined whether 
treatment resulted 
in an increase in 
social functioning 
for experimental 
group compared to 
control  
experimental/control 
group were taking 
part in any therapy or 
self-help classes 
 
- Intervention lasted 
only 12 weeks 
 
- 6 participants 
dropped out of 
experimental group, 
3 from control  
 
 
Strengths 
- Innovative  
- Other studies have 
examined the effects 
of  animal assisted 
therapy 
 
areas such as sensory 
integration and 
directed attention 
 
- Participants 
demonstrated a 
sustained level of 
directed attention and 
focus, usually not 
seen in children with 
ASD 
Risperidone and 
Explosive 
Aggressive 
Autism 
 
 
Horrigan JP, & 
To explore the 
application of 
risperidone in a 
broader age range 
of autistic 
individuals with 
severe explosive 
- Quantitative and 
Qualitative 
 
- Complete physical 
examination, 
including a 
neurological 
- Autism had to be 
primary condition  
 
- Risperidone 
administered in an 
open-label, 
nonblind fashion to 
Limitations  
- Possible that 
risperidone may have 
lowered the seizure 
threshold in a 
vulnerable 
individual, similar to 
- Substantial clinical 
improvement was 
noted almost 
immediately in each 
patient, with 
aggression, self-
injury, explosivity, 
BENEFITS OF NONPHARMACOLOGICAL AND PHARMACOLOGICAL TREATMENTS IN AUTISTIC CHILDREN 
 
32 
Author (Year) 
Title 
Citation 
Purpose Design and Sample Methods Limitations and 
Strengths 
Findings 
Barnhill LJ. 
(1997). 
Risperidone and 
explosive 
aggressive 
autism. Journal of 
Autism & 
Developmental 
Disorders, 27(3), 
313–323. 
Retrieved from 
https://search.ebs
cohost.com/login.
aspx?direct=true
&db=ccm&AN=1
05822413&site=e
ds-live 
aggressive, with 
the supposition 
being that 
risperidone might 
prove to be a more 
effective and better 
tolerated agent 
than the other 
classes of 
medications 
examination and lab 
work  
 
- Side effects 
monitored via 
standardized 
questions 
addressing such 
issues as changes in 
appetite or sleep 
hygiene, somatic 
complaints  
 
11 males 
 
- Patient age range 
from 6-34 years old 
  
the potential of other 
neuroleptics 
 
- A larger scale, 
placebo-controlled 
study involving both 
sexes would be 
worthwhile to 
confirm these initial 
findings 
 
- Little written on the 
use of risperidone in 
the autistic 
population  
 
Strengths  
- Further develop and 
learn about 
risperidone effects on 
autism  
 
- Treatment was 
individualized for 
each candidate, doses 
were titrated 
upwards, gauged by 
adult caretaker report  
 
and poor sleep 
hygiene most 
improved 
 
- Marked clinical 
improvement was 
noted in each patient, 
with the most 
significant gains 
noted within the first 
24 hours of 
risperidone therapy 
in all but one patient 
(Patient A) 
 
- Aggression (hitting, 
kicking, biting), self 
injury (head-banging, 
self-biting), 
explosivity (sudden, 
intense tantrums 
occurring with little 
or no provocation), 
overactivity 
(persistently elevated 
levels of motor 
activity), and poor 
sleep hygiene 
(difficulty falling 
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Author (Year) 
Title 
Citation 
Purpose Design and Sample Methods Limitations and 
Strengths 
Findings 
 
 
asleep, difficulty 
staying asleep) 
diminished most 
significantly 
 
- Further advances in 
the dose were ceased 
after the onset of 
unwanted side effects 
or after all parties 
had agreed that a 
satisfactory degree of 
improvement had 
occurred 
Effects of water 
exercise 
swimming 
program on 
aquatic skills and 
social behaviors 
in children with 
autism spectrum 
disorders  
 
 
Pan, C.-Y. 
(2010). Effects of 
Water Exercise 
To determine the 
effectiveness of a 
10 week water 
exercise swimming 
program (WESP) 
on the aquatic 
skills and social 
behaviors of 16 
boys with autism 
spectrum disorders 
(ASD) 
- Quantitative, 
experimental design  
 
- Controlled, single-
blind design  
 
- Within-participant 
repeated measures 
design  
 
- Each participant 
was assessed 3 
times, once at study 
entry (baseline), 
second time after 10 
weeks of regular 
treatment/activity, 
third time after 
another 10 weeks  
 
Limitations  
- Low same size, 
small age range, and 
single gender of 
participants (male) 
 
- Difference in 
cognitive abilities 
and gross motor 
skills were not 
evaluated and might 
have influenced 
findings  
 
- Analysis revealed a 
significant main 
effect of time on the 
academic behavior 
and all antisocial 
behaviors 
 
- Results indicated 
that the WESP 
improved the aquatic 
skills in 4/5 stages as 
measured with 
percentage scores, 
and decreased the 
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Author (Year) 
Title 
Citation 
Purpose Design and Sample Methods Limitations and 
Strengths 
Findings 
Swimming 
Program on 
Aquatic Skills 
and Social 
Behaviors in 
Children with 
Autism Spectrum 
Disorders. 
Autism: The 
International 
Journal of 
Research and 
Practice, 14(1), 
9–28. Retrieved 
from 
https://search.ebs
cohost.com/login.
aspx?direct=true
&db=eric&AN=E
J872183&site=ed
s-live 
 
- More research 
needed to understand 
the impact of these 
variables on health-
promoting physical 
activities in this 
population 
 
Strengths 
- WESP starts with a 
mental adjustment to 
the activity and 
factors associated 
with it. As the 
program progressed, 
more dynamic and 
challenging tasks  
 
- Aquatic activity 
exercises the total 
body without putting 
excessive stress or 
tension on specific 
body parts 
 
- Instructors and 
children perform the 
same techniques, and 
this provides 
total antisocial 
behavior problems in 
children with ASD 
 
- All strategies 
implemented with 
the goal of making 
the social interaction 
mutually reinforcing 
to both the children 
with ASDs and their 
instructors and peers  
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Author (Year) 
Title 
Citation 
Purpose Design and Sample Methods Limitations and 
Strengths 
Findings 
opportunities for 
children and parents 
to participate 
together following 
identical routines  
Effectiveness of 
Sensory 
Integration 
Interventions in 
Children with 
Autism Spectrum 
Disorders: A Pilot 
Study 
 
Pfeiffer, B. A., 
Koenig, K., 
Kinnealey, M., 
Sheppard, M., & 
Henderson, L. 
(2011). 
Effectiveness of 
sensory 
integration 
interventions in 
children with 
autism spectrum 
disorders: a pilot 
study. American 
To provide 
preliminary 
information on the 
effectiveness of SI 
interventions for 
children with 
ASDs and to 
obtain pilot data to 
guide future  
- Pilot study 
 
 
 
 
- Children ages 6-12 
with ASD who 
attended a summer 
therapeutic 
activities program, 
were randomly 
assigned to a fine 
motor or SI 
treatment group 
 
- Total of 32 boys 
and 5 girls, similar 
to ratio of ASD 
 
- Interventions were 
provided in context 
of the summer 
therapeutic 
activities program 
 
  
Limitations  
- Issues with 
objective 
measurement tools 
for children on the 
autistic spectrum 
(standardized 
measures are 
inappropriate 
because of the wide 
variety in behavioral 
and developmental 
levels and the ability 
of a child with ASD 
to complete the test 
while maintaining 
test validity 
 
- Ensure participants 
are more 
homogenous so 
effectiveness of 
interventions can be 
- Results identified 
significant positive 
changes in Goal 
Attainment SCaling 
scores for both 
groups, more 
significant changes 
occurred in the SI 
group, and a 
significant decrease 
in autistic 
mannerisms occurred 
in the SI group 
 
- Results showed 
significant post 
intervention 
differences in social 
responsiveness 
between the SI and 
FM group 
 
- Children in the SI 
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Author (Year) 
Title 
Citation 
Purpose Design and Sample Methods Limitations and 
Strengths 
Findings 
Journal of 
Occupational 
Therapy, 65(1), 
76–85. 
https://doi.org/10.
5014/ajot.2011.09
205 
 
detected, the group in 
this study varied 
greatly in their 
adaptive behavioral 
levels   
 
- Carry over 
interventions 
throughout daily 
routines which is 
more characteristic 
of OT services, and 
use measurement 
tools that are more 
individualized due to 
the diverse nature of 
people with autism  
 
- This study was over 
a short period of 
time, 3x/week for 6 
weeks 
 
Strengths  
- Multiple 
procedures/measure
ment tools used to 
identify and narrow 
results  
group had 
significantly fewer 
autistic mannerisms 
after interventions  
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Author (Year) 
Title 
Citation 
Purpose Design and Sample Methods Limitations and 
Strengths 
Findings 
 
- Treatment 
interventions were 
based on the 
individual needs of 
each child but 
included the 10 key 
therapeutic strategies 
identified in the 
fidelity tool  
 
- Results of study 
were mixed yet 
demonstrated 
significant changes 
in the autistic 
mannerisms 
(component of social 
responsiveness) and 
significant progress 
toward individual 
goals in the areas of 
sensory processing 
and regulation, 
social-emotional 
function, and FM 
skills 
Psychotropic To examine - Quantitative  - IAN project data: Limitations  - A total of 
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Author (Year) 
Title 
Citation 
Purpose Design and Sample Methods Limitations and 
Strengths 
Findings 
Medication Use 
Among Children 
With Autism 
Spectrum 
Disorders 
Enrolled in a 
National Registry, 
2007-2008 
 
 
Rosenberg RE, 
Mandell DS, 
Farmer JE, Law 
JK, Marvin AR, 
& Law PA. 
(2010). 
Psychotropic 
medication use 
among children 
with autism 
spectrum 
disorders enrolled 
in a National 
Registry, 2007-
2008. Journal of 
Autism & 
Developmental 
Disorders, 40(3), 
342–351. 
patterns of current 
psychotropic 
medication use 
among 5,181 
children with 
autism spectrum 
disorders (ASD) 
enrolled in a Web-
based registry 
 
1. Confirm 
Mandell’s findings 
regarding factors 
influence 
psychotropic 
medication use and 
comparative 
prevalence in a 
unique national 
dataset, the 
Interactive Autism 
Network (IAN) 
which includes 
children of varying 
insurance status 
 
2. Test the 
hypothesis that 
insurance status—
 
- IAN: Internet 
based research 
database 
 
All families 
complete an initial 
registration and 
then are invited to 
complete several 
other 
questionnaires, 
including a profile 
on each affected 
child and a list of 
treatments that the 
child currently 
receives 
 
- Families do not 
supply overall 
insurance status in 
the IAN survey. 
Therefore, to 
examine the effects 
of type of insurance 
on psychotropic 
medication use, we 
examined data from 
all subjects who 
reported use of at 
least one 
medication and who 
reported payer 
- The data are 
provided by Web-
based parent-report, 
so diagnosis and 
treatment use are not 
validated 
 
- Selection bias, 
common to other 
community- and 
clinic-based studies, 
toward families with 
higher 
socioeconomic status 
(SES) and with 
Internet access 
 
- The insurance data 
were linked to 
individual treatments 
rather than 
individuals, and did 
not specify the 
reason for Medicaid 
eligibility (disability, 
income, or both) 
 
- The data include 
information only on 
5,181 children in our 
sample had complete 
child and treatment 
information from 
April 2007 through 
October 20, 2008. 
The sample was 
predominantly 6–11 
years of age (49%), 
was mostly male 
(83%), and often 
reported psychiatric 
comorbidities (39% 
with ≥ 
1 comorbidity) 
 
- Overall, 35.3% of 
subjects used at least 
one psychotropic 
medication at the 
time of survey 
completion 
 
- The most common 
psychotropic 
medications were 
stimulants, 
neuroleptics, and 
antidepressants 
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in addition to the 
demographic 
variables 
previously 
associated with 
medication use—
affects use of 
prescription 
medications in 
ASD 
 
3. Investigate 
prescribing trends 
by medical 
specialty for 
children with ASD, 
given limited if 
any research in this 
area 
information about 
that medication 
the history of (not 
current status) 
seizure disorder, we 
are not able to 
determine if 
anticonvulsants are 
being prescribed for 
mood-stabilizing or 
antiepileptic 
properties 
 
Strengths  
- Compared and 
strengthened 
previous studies 
about psychotropic 
med use and in this 
study, addressed 
demographics and 
insurance status  
 
 
- White and African 
American 
participants reported 
similar percentages 
of psychotropic 
medication use 
 
- Hispanic 
participants were less 
likely to use any 
psychotropic 
medication 
 
- Among those 
children using a 
psychotropic 
medication with 
analyzable data (n = 
1,575), those with no 
reported insurance 
coverage were 
significantly less 
likely to be on more 
than two medications 
than were those with 
private insurance, 
Medicaid, or a 
combination of 
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Psychotropic 
Medication Use 
and 
Polypharmacy in 
Children With 
Autism Spectrum 
Disorders 
 
 
Spencer, D., 
Marshall, J., Post, 
B., Kulakodlu, 
M., Newschaffer, 
C., Dennen, T., 
Azocar, F., Jain, 
A. (2013, October 
21). Psychotropic 
Medication Use 
and 
Polypharmacy in 
Children With 
Autism Spectrum 
Disorders. 
Pediatrics. 
To examine rates 
and predictors of 
psychotropic use 
and multiclass 
polypharmacy 
among 
commercially 
insured children 
with autism 
spectrum disorders 
(ASD) 
 
 
- Retrospective 
observational study 
using an 
administrative 
claims database 
associated with a 
large US 
commercial health 
plan 
- Using medical and 
pharmacy claims 
data with linked 
enrollment 
information, a total 
of 33 565 children 
with ASD who had 
at least 6 months of 
continuous medical, 
pharmacy, and 
behavioral health 
care coverage 
between January 
2001 and December 
2009 were 
identified 
 
- Eligible subjects 
had to be between 
the age of 0 and 20 
years as of their 
first day of health 
plan enrollment 
during the study and 
without claims for 
childhood 
Limitations  
- Misclassification of 
subjects with and 
without ASD is 
possible 
 
- Administrative 
claims data can be 
used to document 
prescription fills but 
not whether the 
patient actually took 
the prescribed 
medication or as 
directed, and claims 
do not capture over-
the counter 
medications 
 
- Did not examine 
dose or 
appropriateness of 
dose for a particular 
child or a particular 
diagnosis because 
appropriate dosing 
- More white 
children children 
ages 11 and older, 
had evidence of both 
psychotropic use and 
polypharmacy 
 
- A large proportion 
of children with 
evidence of epilepsy/ 
seizures, ADD, 
anxiety, depression, 
and/or bipolar 
disorder were 
psychotropic users, 
and one-half or more 
had evidence of 
polypharmacy 
 
- Among a sample of 
33,565 commercially 
insured children with 
ASD in the United 
States, we found that 
64% used at least 1 
psychotropic 
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disintegrative 
disorder or Rett 
syndrome 
 
- Subjects were 
required to have 1 
period of at least 6 
months of 
continuous 
enrollment but may 
have had more 
enrollment time 
with all 3 types of 
coverage during the 
study 
often depends on a 
child’s weight 
(possibly resulted in 
overestimation of 
psychotropic use and 
polypharmacy) 
 
Strengths 
- Detailing 
psychotropic use and 
polypharmacy 
among children with 
ASD is crucial for 
informing families, 
clinicians, and 
researchers  
 
 
medication, and just 
more than one-third 
had evidence of 
psychotropic 
polypharmacy during 
an average length of 
enrollment of 3+ 
years 
 
- Children from the 
southern region were 
significantly more 
likely than children 
from the northeast 
and west to be 
multiclass 
polypharmacy users, 
raising questions 
about the availability 
of 
nonpharmacologic, 
behaviorally based 
services and 
treatments in the 
south, where other 
health outcomes and 
health care services 
have been found to 
be poorer than in 
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- Study highlights the 
need for primary care 
providers to carefully 
elicit medication 
histories and monitor 
symptoms for 
evidence of 
effectiveness 
Immediate Effect 
of Ayres’s 
Sensory 
Integration-Based 
Occupational 
Therapy 
Intervention on 
Children With 
Autism Spectrum 
Disorders 
 
 
Watling RL, & 
Dietz J. (2007). 
Immediate effect 
of Ayres’s 
sensory 
To examine the 
effects of Ayres’s 
sensory integration 
intervention on the 
behavior and task 
engagement of 
young children 
with autism 
spectrum disorders 
(ASD) 
- Single-subject 
study used ABAB 
design to compare 
immediate effect of 
Ayres’s sensory 
integration and a 
play scenario on the 
undesired behavior 
and task 
engagement of 4 
children with ASD 
- 4 boys between 
age 3 years 0 
months - 4 years 4 
months 
 
- Independently 
diagnosed with 
ASD  
- No comorbid 
diagnoses, absence 
of seizures, no 
concurrent OT 
services, no 
intention to 
add/change meds or 
therapy during 
course of study 
Limitations  
- Constraints 
imposed by the 
operational definition 
of engagement  
 
- Small sample size  
 
- Complications in 
rating engagement  
 
- Short duration of 
the A2 pashes  
 
- Potential bias in 
subjective 
observations 
- Data suggested that 
Ayres’s sensory 
integration had a 
positive effect on 
transitions, 
socialization, 
compliance, and 
general behavior 
regulation, evident 
during intervention 
sessions and at in 
home environments 
 
- Subjective data 
recorded in the study 
logs suggest that new 
behaviors emerged 
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Retrieved from 
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cohost.com/login.
aspx?direct=true
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ds-live 
recorded by study 
personnel and 
caregivers  
 
 
Strengths  
- Study was carried 
out in a systematic 
manner and 
treatment sessions 
met proposed criteria 
for Ayres’s sensory 
integration 
 
- Both interventions 
were carried out by 
same OT, controlling 
effect of therapist 
characteristics on 
therapist-participant 
interaction  
 
- Raters for 
engagement and 
undesired behavior 
were blind to which 
intervention 
condition preceded 
the data collection 
during the Ayres’s 
sensory integration 
sessions for each 
participant; 
behaviors changed in 
home environments 
as well  
 
- Results of this 
study were consistent 
with those reported 
by Smith et al. 
(2005), who found 
no change in 
frequency of 
undesired behaviors 
immediately after 
Ayres’s sensory 
integration  
BENEFITS OF NONPHARMACOLOGICAL AND PHARMACOLOGICAL TREATMENTS IN AUTISTIC CHILDREN 
 
44 
Author (Year) 
Title 
Citation 
Purpose Design and Sample Methods Limitations and 
Strengths 
Findings 
period  
 
- Study had high 
interrater agreement 
on the dependent 
variable ratings and 
high procedural 
reliability  
 
 
